Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adaptimmune Therapeutics

    NASDAQ: ADAP · Real-Time Price · USD
    0.28
    -0.00 (-1.06%)
    At close: Jun 09, 2025, 3:58 PM

    Adaptimmune Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -70.81M -113.87M -165.46M -158.09M
    Depreciation & Amortization
    		 10.81M 9.45M 6.08M 6.57M
    Stock-Based Compensation
    		 12.05M 11.77M 18.24M 20.63M
    Other Working Capital
    		 -29.64M -25.05M -1.53M 134.63M
    Other Non-Cash Items
    		 11.31M -23.67M 903K 6.99M
    Deferred Income Tax
    		 n/a n/a n/a 5.82M
    Change in Working Capital
    		 -36.99M -24.95M -1.53M 134.62M
    Operating Cash Flow
    		 -73.21M -140.88M -141.77M 10.73M
    Capital Expenditures
    		 -2.72M -4.88M -29.74M -8.78M
    Cash Acquisitions
    		 n/a 45.26M 77.86M 207K
    Purchase of Investments
    		 -100.42M -75.95M -48.12M -139.75M
    Sales Maturities Of Investments
    		 44.06M 210.98M 166.89M 224.32M
    Other Investing Acitivies
    		 129.05K 1.13M -77.86M -207K
    Investing Cash Flow
    		 -58.95M 176.54M 89.14M 75.8M
    Debt Repayment
    		 49.5M n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 77K 256K 50K 759K
    Financial Cash Flow
    		 78.75M 880K 12.87M 3.29M
    Net Cash Flow
    		 -53.81M 37.41M -42.06M 90.18M
    Free Cash Flow
    		 -75.93M -145.76M -171.51M 1.95M

    Add to Watchlist